Literature DB >> 10960593

Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord.

S Y Chow1, J Moul, C A Tobias, B T Himes, Y Liu, M Obrocka, L Hodge, A Tessler, I Fischer.   

Abstract

Recent advances in the isolation and characterization of neural precursor cells suggest that they have properties that would make them useful transplants for the treatment of central nervous system disorders. We demonstrate here that spinal cord cells isolated from embryonic day 14 Sprague-Dawley and Fischer 344 rats possess characteristics of precursor cells. They proliferate as undifferentiated neurospheres in the presence of EGF and bFGF and can be maintained in vitro or frozen, expanded and induced to differentiate into both neurons and glia. Exposure of these cells to serum in the absence of EGF and bFGF promotes differentiation into astrocytes; treatment with retinoic acid promotes differentiation into neurons. Spinal cord cells labeled with a nuclear dye or a recombinant adenovirus vector carrying the lacZ gene survive grafting into the injured spinal cord of immunosuppressed Sprague-Dawley rats and non-immunosuppressed Fischer 344 rats for up to 4 months following transplantation. In the presence of exogenously supplied BDNF, the grafted cells differentiate into both neurons and glia. These spinal cord cell grafts are permissive for growth by several populations of host axons, especially when combined with exogenous BDNF administration, as demonstrated by penetration into the graft of axons immunopositive for 5-HT and CGRP. Thus, precursor cells isolated from the embryonic spinal cord of rats, expanded in culture and genetically modified, are a promising type of transplant for repair of the injured spinal cord.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960593     DOI: 10.1016/s0006-8993(00)02443-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  27 in total

1.  Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI.

Authors:  Philip J Johnson; Alexander Tatara; Dylan A McCreedy; Alicia Shiu; Shelly E Sakiyama-Elbert
Journal:  Soft Matter       Date:  2010-10-21       Impact factor: 3.679

Review 2.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

Review 3.  Intermittent hypoxia and neurorehabilitation.

Authors:  Elisa J Gonzalez-Rothi; Kun-Ze Lee; Erica A Dale; Paul J Reier; Gordon S Mitchell; David D Fuller
Journal:  J Appl Physiol (1985)       Date:  2015-05-21

4.  Neuronal progenitor transplantation and respiratory outcomes following upper cervical spinal cord injury in adult rats.

Authors:  Todd E White; Michael A Lane; Milapjit S Sandhu; Barbara E O'Steen; David D Fuller; Paul J Reier
Journal:  Exp Neurol       Date:  2010-06-18       Impact factor: 5.330

5.  Intraspinal application of endothelin results in focal ischemic injury of spinal gray matter and restricts the differentiation of engrafted neural stem cells.

Authors:  Richard L Benton; John P Woock; Evelyne Gozal; Michal Hetman; Scott R Whittemore
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

6.  The Therapeutic Effectiveness of Delayed Fetal Spinal Cord Tissue Transplantation on Respiratory Function Following Mid-Cervical Spinal Cord Injury.

Authors:  Chia-Ching Lin; Sih-Rong Lai; Yu-Han Shao; Chun-Lin Chen; Kun-Ze Lee
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

7.  Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells.

Authors:  Qilin Cao; Xiao-Ming Xu; William H Devries; Gaby U Enzmann; Peipei Ping; Pantelis Tsoulfas; Patrick M Wood; Mary Bartlett Bunge; Scott R Whittemore
Journal:  J Neurosci       Date:  2005-07-27       Impact factor: 6.167

8.  Intraspinal transplantation and modulation of donor neuron electrophysiological activity.

Authors:  Kun-Ze Lee; Michael A Lane; Brendan J Dougherty; Lynne M Mercier; Milapjit S Sandhu; Justin C Sanchez; Paul J Reier; David D Fuller
Journal:  Exp Neurol       Date:  2013-11-02       Impact factor: 5.330

9.  Safety of human neural stem cell transplantation in chronic spinal cord injury.

Authors:  Katja M Piltti; Desiree L Salazar; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

10.  Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells.

Authors:  Zhen Li; Scott R McKercher; Jiankun Cui; Zhiguo Nie; Walid Soussou; Amanda J Roberts; Tina Sallmen; Jeffrey H Lipton; Maria Talantova; Shu-ichi Okamoto; Stuart A Lipton
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.